ETS2 and breast cancer: For ETS2 and KLF2, despite promoter accessibility (as shown by H3K4me3, RNA Pol II binding, and ATAC-seq data), RNA-seq and GRO-seq profiles indicated a “poised but not transcribed” promoter state for both TFs, which may account for their downregulation in BC.